These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22185030)

  • 1. [Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?].
    Ter Arkh; 2011; 83(10):68-71. PubMed ID: 22185030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
    Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
    Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy and proton pump inhibition: clinician update.
    Moukarbel GV; Bhatt DL
    Circulation; 2012 Jan; 125(2):375-80. PubMed ID: 22249527
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
    Gellatly RM; Ackman ML
    Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and clopidogrel: is it a significant drug interaction?
    Oyetayo OO; Talbert RL
    Expert Opin Drug Saf; 2010 Jul; 9(4):593-602. PubMed ID: 20377472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with high gastrointestinal risk on antiplatelet therapy.
    Cryer B
    Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
    Juhász M; Herszényi L; Tulassay Z
    Digestion; 2010; 81(1):10-5. PubMed ID: 20029203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.
    Tan VP; Yan BP; Hunt RH; Wong BC
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1342-7. PubMed ID: 20659222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 13. Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
    Tan HJ; Mahadeva S; Menon J; Ng WK; Zainal Abidin I; Chan FK; Goh KL; ;
    J Dig Dis; 2013 Jan; 14(1):1-10. PubMed ID: 23134105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M; Naunton M; Peterson GM; Bereznicki L
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
    Struijk M; Postma DF; van Tuyl SA; van de Ree MA
    Eur J Intern Med; 2012 Apr; 23(3):227-30. PubMed ID: 22385878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy and proton pump inhibition: cause for concern?
    Depta JP; Bhatt DL
    Curr Opin Cardiol; 2012 Nov; 27(6):642-50. PubMed ID: 23075823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Interaction between clopidogrel and proton pump inhibitors.
    Howard PA; Vacek JL
    Am J Cardiovasc Drugs; 2009; 9(6):353-9. PubMed ID: 19929033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
    Hokimoto S; Matsui K; Oshima S; Noda K; Kaikita K; Sumida H; Sugiyama S; Ogawa H
    J Cardiol; 2009 Aug; 54(1):71-5. PubMed ID: 19632523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.